Swiss pharma giant Roche announced Tuesday the launch of a new test to help researchers find coronavirus variants which are feared to be more harmful or could undermine vaccines.

The new laboratory test is designed to detect mutations on the virus and monitor their prevalence and potential impact on infection, vaccines and therapies to combat COVID-19, the disease it causes, Roche said in a statement.

“Continuous surveillance is essential to public health,” Roche said.

The appearance of variants has caused much concern in recent months with those from the UK, Brazil and South Africa in particular widely believed to be more transmissible and possibly more dangerous.

Roche’s new test can be run on its Cobas 6800/8800 machines which are widely used in research laboratories and hospitals, it said.

Roche has been a pioneer in coronavirus testing since the virus first surfaced in China in late 2019 before spreading around the world.

– AFP

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments
You May Also Like

Critics say treaty text in international accord by WHO member states on pandemic is ‘step backwards’

Observers warn of weakened efforts to ensure equitable access to medical products in negotiations for a new pandemic treaty. Critics express concern over revisions that water down language aimed at addressing the inequity in accessing vaccines and medical products during the COVID pandemic. Urgency grows to align positions before the looming threat of future pandemics.

Two Chinese cities sealed off to squash virus outbreak

China has sealed off two cities south of Beijing, cutting transport links…

1 in 3 COVID survivors suffer mental, neurological problems: study

by Patrick Galey One in three people who overcome COVID-19 suffer from…

12 new cases of COVID-19 infection in S’pore; all cases are imported

As of Monday noon (22 Mar), the Ministry of Health (MOH) has…